Compound information
- Natural Products
- ZC194514
- Molecular Formula
- C10H11NO2
- Molecular Weight
- 177.078978592 g/mol
- Structure
-
- IUPAC Name
- N-(4-methoxyphenyl)prop-2-enamide
- InChI
- InChI=1S/C10H11NO2/c1-3-10(12)11-8-4-6-9(13-2)7-5-8/h3-7H,1H2,2H3,(H,11,12)
- InChI Key
- YMHDGRAROYGJLT-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(OC)cc1
- Source
- ZINC000003194611
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 13 | Ring Count | 1 |
Heteroatom Count | 3 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 38.33 Å2 | LogP | 1.878 |
LogS | -2.689 | LogD | 1.857 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.035 | Pgp substrate | 0.342 |
HIA | 0.965 | F20 % | 0.992 |
F30 % | 0.435 | Caco-2 | -4.449 |
MDCK | -4.631 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.932 | PPB | 77.548 |
VD | 0.719 | Fu | 0.889 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.996 | CYP1A2 substrate | 0.671 |
CYP2A6 substrate | 0.775 | CYP2B6 substrate | 0.488 |
CYP2C19 inhibitor | 0.453 | CYP2C19 substrate | 0.745 |
CYP2C8 substrate | 0.714 | CYP2C9 inhibitor | 0.024 |
CYP2C9 substrate | 0.464 | CYP2D6 inhibitor | 0.026 |
CYP2D6 substrate | 0.859 | CYP2E1 substrate | 0.952 |
CYP3A4 inhibitor | 0.01 | CYP3A4 substrate | 0.563 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.523 | CL | 12.349 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.009 | Hepatotoxicity | 0.924 |
Mutagenicity | 0.137 | Rat Oral Acute Toxicity | 0.041 |
FDAMDD | 0.204 | Skin Sensitization | 0.999 |
Carcinogenicity | 0.666 | Eye Corrosion | 0.473 |
Eye Irritation | 0.964 | Respiratory Toxicity | 0.147 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.721 | IGC50 | 3.167 |
LC50FM | 4.317 | LC50DM | 4.372 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.16 | NR-AR-LBD | 0.233 |
NR-AhR | 0.472 | NR-Aromatase | 0.069 |
NR-ER | 0.649 | NR-ER-LBD | 0.425 |
NR-PPAR-gamma | 0.729 | SR-ARE | 0.831 |
SR-ATAD5 | 0.714 | SR-HSE | 0.16 |
SR-MMP | 0.16 | SR-p53 | 0.761 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.